Presentation TCT 2016 Outcomes and Role of Ablation in the Treatment Approach to Atrial Fibrillation Presenter: Vivek Y. Reddy October 30, 2016 REGISTER for free or LOG IN to view this content Structural Heart Presentation TCT 2016 Left Atrial Appendage Up Next Presentation TCT 2016 Meta-analysis and Synthesis of Watchman Trials: Relative Safety and Efficacy vs Warfarin and NOACs in Anticoagulant Indicated Patients (Including Cost-effectiveness) Presenter: Vivek Y. Reddy October 30, 2016 More slides + Presentation TCT 2016 Use of Watchman in Anticoagulant Contraindicated Patients: Has Safety and Efficacy Been Proven? Presenter: David R. Holmes Jr. October 30, 2016 Presentation TCT 2016 Synthesis of ACP/Amulet Studies in Anticoagulated Indicated and Contra-indicated Patients: Certainties, Data Gaps, and Future Studies Presenter: Apostolos Tzikas October 30, 2016 We Recommend
Presentation TCT 2016 Meta-analysis and Synthesis of Watchman Trials: Relative Safety and Efficacy vs Warfarin and NOACs in Anticoagulant Indicated Patients (Including Cost-effectiveness) Presenter: Vivek Y. Reddy October 30, 2016
Presentation TCT 2016 Use of Watchman in Anticoagulant Contraindicated Patients: Has Safety and Efficacy Been Proven? Presenter: David R. Holmes Jr. October 30, 2016
Presentation TCT 2016 Synthesis of ACP/Amulet Studies in Anticoagulated Indicated and Contra-indicated Patients: Certainties, Data Gaps, and Future Studies Presenter: Apostolos Tzikas October 30, 2016